Max Robotics — Global Service Robot Directory + US Certification

About

Mitchell Hayes is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for renal cell carcinoma (RCC), particularly in complex cases involving tumor thrombus. His major contributions center on comparing the efficacy and safety of open, laparoscopic, and robotic surgical approaches for radical nephrectomy with tumor thrombectomy (RN-TT) and cytoreductive nephrectomy with tumor thrombectomy (CN-TT) in metastatic disease. Through the Intercontinental Collaboration on Renal Cell Carcinoma, Hayes has provided critical evidence guiding surgical decision-making, demonstrating that while open surgery remains the gold standard, minimally invasive approaches offer comparable outcomes with reduced morbidity in select patients. His work, including highly cited studies from 2025, has directly influenced clinical guidelines for managing RCC with venous extension. With over 2,000 citations across his portfolio, Hayes is recognized for advancing the field of robotic urologic surgery and improving survival outcomes for patients with advanced kidney cancer. His ongoing research continues to refine surgical techniques and patient selection criteria, solidifying his reputation as a pioneer in complex renal cancer surgery.